Antibody response to Aedes aegypti D7L1 + 2 salivary proteins as marker of aggregate vector exposure and correlate of dengue virus susceptibility

Aedes aegypti mosquitoes transmit several arboviruses of public health importance. Among these is dengue virus (DENV), a flavivirus whose global infection rates continue to rise each year. With limited options available for preventing or treating DENV infections, mosquito control remains the most widely implemented strategy to combat DENV transmission. Due to the global distribution of DENV, which infects an estimated 400 million people per year, vector suppression practices vary drastically by country and/or region and even small differences in microenvironment can significantly impact vector abundance. There remains a significant need to better understand vector exposure rates at an individual level to disentangle vector exposure and arboviral infection rates. To this end, we have optimized a serologic assay to assess the abundance of antibodies directed against the mosquito salivary proteins AeD7L1 + 2 as a surrogate metric of vector exposure. Utilizing this assay, we found that anti-AeD7L1 + 2 IgG levels were unable to identify low levels of Aedes exposure in individuals with limited prior Aedes exposure, indicating they are unreliable markers of an individual's recent exposure to low levels of these vectors. However, antibody levels against AeD7L1 + 2 were robust in plasma samples from individuals living in Aedes endemic regions. These antibody levels reflected seasonal changes in Aedes abundance and exposure, indicating their potential for use as an aggregate marker of vector exposure. Additionally, we found that there were negative associations with anti-AeD7L1 + 2 IgG levels and age in our cohort. Interestingly, we also found that lower titers of anti-AeD7L1 + 2 IgG correlated with higher infection burden in households. This finding has implications for the potential interaction between AeD7L1 + 2 proteins or anti-AeD7L1 + 2 antibodies and DENV during infection events that will require further study.

Authors

Institutions

Publication Details

Journal
PLoS neglected tropical diseases
Published
2025-10-29
DOI
https://doi.org/10.1371/journal.pntd.0013099
Citations
1
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
1.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antibody response to Aedes aegypti D7L1 + 2 salivary proteins as marker of aggregate vector exposure and correlate of dengue virus susceptibility

Lauren E. Bahr, Ivona Petzlova, Kathryn B. Anderson, Darunee Buddhari et al.
1 citations
PLoS neglected tropical diseases
Mosquito-borne diseases and control
1.88
article

Antibody response to Aedes aegypti D7L1 + 2 salivary proteins as marker of aggregate vector exposure and correlate of dengue virus susceptibility

Lauren E. Bahr, Ivona Petzlova, Kathryn B. Anderson, Darunee Buddhari, Fabiano Oliveira, Stephen James Thomas, Marco Hamins-Puértolas, Adam T. Waickman, Saravanan Thangamani
article en
1 citations

Abstract

Aedes aegypti mosquitoes transmit several arboviruses of public health importance. Among these is dengue virus (DENV), a flavivirus whose global infection rates continue to rise each year. With limited options available for preventing or treating DENV infections, mosquito control remains the most widely implemented strategy to combat DENV transmission. Due to the global distribution of DENV, which infects an estimated 400 million people per year, vector suppression practices vary drastically by country and/or region and even small differences in microenvironment can significantly impact vector abundance. There remains a significant need to better understand vector exposure rates at an individual level to disentangle vector exposure and arboviral infection rates. To this end, we have optimized a serologic assay to assess the abundance of antibodies directed against the mosquito salivary proteins AeD7L1 + 2 as a surrogate metric of vector exposure. Utilizing this assay, we found that anti-AeD7L1 + 2 IgG levels were unable to identify low levels of Aedes exposure in individuals with limited prior Aedes exposure, indicating they are unreliable markers of an individual's recent exposure to low levels of these vectors. However, antibody levels against AeD7L1 + 2 were robust in plasma samples from individuals living in Aedes endemic regions. These antibody levels reflected seasonal changes in Aedes abundance and exposure, indicating their potential for use as an aggregate marker of vector exposure. Additionally, we found that there were negative associations with anti-AeD7L1 + 2 IgG levels and age in our cohort. Interestingly, we also found that lower titers of anti-AeD7L1 + 2 IgG correlated with higher infection burden in households. This finding has implications for the potential interaction between AeD7L1 + 2 proteins or anti-AeD7L1 + 2 antibodies and DENV during infection events that will require further study.

PLoS neglected tropical diseasesVol. 19(10)
National Institutes of Health (US), University of California, San Francisco (US), SUNY Upstate Medical University (US), Armed Forces Research Institute of Medical Science (TH), National Institute of Allergy and Infectious Diseases (US)
Openalex Percentile: Top 11%
Mosquito-borne diseases and control
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.